치과용 지르코니아의 in vitro 및 in vivo 생물학적 평가

다국어 초록 (Multilingual Abstract)

Recently, zirconia ceramics have been extensively used as the artificial tooth in modern dentistry on account of their excellent mechanical properties and good esthetics. The purpose of this study was to evaluate biocompatibility of zirconia ceramics using agar diffusion test, acute systemic toxicity, intracutaneous test and local lymph node assay(LLNA). For in vitro test, the agar diffusion assay was used sintered zirconia specimens (In-ceram YZ-55, VITA Co., Bad sackingen, Germany) were performed according to ISO 7405. For in vivo test, three different tests were carried out and samples were prepared according to ISO 10993-12 for all of the test. Acute systemic toxicity test and Intracutaneous test, were performed according to ISO 10993-11 and ISO 10993-10. The murine local lymph node assay test was performed according to OECD guide line 442 B. The overall criterion for the cytotoxicity of zirconia sample was 0. For the acute systemic toxicity test, no symptoms were observed during the visual observation of the animal. For the intracutaneous irritation test, there was no redness and swellings on the reaction sites. The result of LLNA test, the samples extractions in polar solvents showed average OD value of 1.078 and those in non-polar solvents showed average OD value of 1.059. The partially stabilized zirconia materials were proved to be biocompatible. The results of both in vitro and in vivo test concluded that the zirconia materials were biocompatible.

참고문헌 (Reference)

1 OECD, "skin sensitization：Local Lymph Node Assay : BrdU-ELISA, Test Guideline No. 442 B, Guidelines for the testing of chemicals"

2 Sollazzo V, "Zirconium oxide coating improves implant osseointegration in vivo" 24 : 357-361, 2008

3 Keisuke N, "Zirconia as a dental implant abutment material : a systematic review" 23 : 299-309, 2010

4 Nakamura K, "Zirconia as a dental implant abutment material : A systemic review" 23 : 299-309, 2010

5 Yoichiro I, "Tissue compatibility and stability of a new zirconia ceramic invivo" 68 : 322-326, 1992

6 Welender M, "The mucosal barrier at implant abutments of different materials" 19 : 635-641, 2008

7 Hallmann L, "The influence of grain size on low-temperature degradation of dental zirconia" 100B : 447-456, 2011

8 Schley JS, "Survival probability of zirconiabased fixed dental prostheses up to 5 yr : a systematic review of the literature" 118 : 443-450, 2010

9 Christel P, "Mechanical properties and short-term in-vivo evaluation of yttrium-oxide-partially-stabilized zirconia" 23 : 45-61, 1989

10 Covacci V, "In vitro evaluation of the mutagenic and carcinogenic power of high purity zirconia ceramic" 20 : 371-376, 1999

11 International Organization for standardization, "ISO 10993-5: Biological evaluation of medical devicespart 5 : Tests for in vitro cytotoxicity"

12 International Organization for standardization, "ISO 10993-11: Biological evaluation of medical devices-part 11 : Tests for systemic toxicity"

13 International Organization for standardization, "ISO 10993-10: Biological evaluation of medical devices-part 10 : Tests for irritation and skin sensitization"

14 Zarone F, "From porcelain-fused-to-metal to zirconia : Clinical and experimental considerations" 27 : 83-96, 2011

15 Li J, "Evaluation of biocompatibility of various ceramic powders with human fibroblasts in vitro" 12 : 197-201, 1993

16 Schmitter M, "Clinical performance of longspan zirconia frameworks for fixed dental prostheses : 5-year results" 39 : 552-557, 2012

17 Hideki W, "Biological reaction to alumina, zirconia, titanium and polyethylene particles implanted onto murine calvaria" 24 : 3655-3661, 2003